J&J gets a $30B Acte­lion buy­out and a new part­ner as Clozel’s team spins out with the pipeline

One of the big hur­dles fac­ing any­one who want­ed to buy Acte­lion was find­ing a way to come up with an ac­cept­able ac­qui­si­tion val­ue for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA